The effect of oseltamivir use in critically ill patients with COVID-19: A multicenter propensity score-matched study

Aljuhani, Ohoud; Korayem, Ghazwa B.; Altebainawi, Ali F.; Alotaibi, Meshal S.; Alrakban, Noura A.; Ghoneim, Ragia H.; Vishwakarma, Ramesh; Al Shaya, Abdulrahman I.; Al Harbi, Shmeylan; Gramish, Jawaher; Almutairi, Dahlia M.; Alqannam, Ghada; Alamri, Faisal F.; Alharthi, Abdullah F.; Alfaifi, Mashael; Al Amer, Abdullah; Alenazi, Abeer A.; Bin Aydan, Norah; Alalawi, Mai; Al Sulaiman, Khalid

doi:10.1016/j.jsps.2023.05.006

Cited by 3 publications

(2 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…33 In a study held among critically ill patients, it was found that patients had a shorter duration of mechanical ventilation when treated with oseltamivir. 64 Additionally, in the same study it was also found that there was no significant difference in the hospital mortality rates of these patients. 64 As per current guidelines, the United States National Institute of Health (NIH) recommends against the use of systemic corticosteroid therapy for patients with mild to moderate COVID-19 infection and in those patients that do not require supplemental oxygen therapy.…”

Section: Discussionmentioning

confidence: 79%

“…64 Additionally, in the same study it was also found that there was no significant difference in the hospital mortality rates of these patients. 64 As per current guidelines, the United States National Institute of Health (NIH) recommends against the use of systemic corticosteroid therapy for patients with mild to moderate COVID-19 infection and in those patients that do not require supplemental oxygen therapy. 65 It was found that systemic corticosteroid therapy is only beneficial when used in patients who require supplement oxygen therapy (conventional oxygen, high flow nasal cannula oxygen, non-invasive ventilation, mechanical ventilation or extracorporeal membrane oxygenation).…”

Section: Discussionmentioning

confidence: 79%

See 1 more Smart Citation

The top 50 most-cited articles about COVID-19 and the complications of COVID-19: A bibliometric analysis

Singh,

Rao Padubidri,

Shetty

et al. 2024

F1000Res

View full text Add to dashboard Cite

Background This bibliometric analysis examines the top 50 most-cited articles on COVID-19 complications, offering insights into the multifaceted impact of the virus. Since its emergence in Wuhan in December 2019, COVID-19 has evolved into a global health crisis, with over 770 million confirmed cases and 6.9 million deaths as of September 2023. Initially recognized as a respiratory illness causing pneumonia and ARDS, its diverse complications extend to cardiovascular, gastrointestinal, renal, hematological, neurological, endocrinological, ophthalmological, hepatobiliary, and dermatological systems. Methods Identifying the top 50 articles from a pool of 5940 in Scopus, the analysis spans November 2019 to July 2021, employing terms related to COVID-19 and complications. Rigorous review criteria excluded non-relevant studies, basic science research, and animal models. The authors independently reviewed articles, considering factors like title, citations, publication year, journal, impact factor, authors, study details, and patient demographics. Results The focus is primarily on 2020 publications (96%), with all articles being open access. Leading journals include The Lancet, NEJM, and JAMA, with prominent contributions from Internal Medicine (46.9%) and Pulmonary Medicine (14.5%). China played a major role (34.9%), followed by France and Belgium. Clinical features were the primary study topic (68%), often utilizing retrospective designs (24%). Among 22,477 patients analyzed, 54.8% were male, with the most common age group being 26-65 years (63.2%). Complications of COVID-19 affected 13.9% of patients, with a recovery rate of 57.8%. Conclusion Analyzing these top-cited articles offers clinicians and researchers a comprehensive, timely understanding of influential COVID-19 literature. This approach uncovers attributes contributing to high citations and provides authors with valuable insights for crafting impactful research. As a strategic tool, this analysis facilitates staying updated and making meaningful contributions to the dynamic field of COVID-19 research.

show abstract

Section: Discussionmentioning

confidence: 79%

Section: Discussionmentioning

confidence: 79%